Ampio Pharmaceuticals Board Approves Reverse Stock Split - Quick Facts
(RTTNews) - Ampio Pharmaceuticals, Inc. (AMPE) said its Board has approved a 20-to-1 reverse stock split of the company's common stock. The reverse stock split will become effective on September 11, 2023. The company's common stock is expected to begin trading on a split-adjusted basis on the NYSE American under the same symbol AMPE when the market opens on September 12, 2023.
The company said, as a result of the reverse stock split, every 20 shares of common stock issued and outstanding will be automatically reclassified into one share of common stock, with no change in the $0.0001 par value per share.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.